Ask Our Doctors and Nurses!

PACLITAXEL Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

PACLITAXEL Safety Reports

Total PACLITAXEL reports: 359.
PACLITAXEL FDA safety alerts: No.
Reported deaths: 62    Reported hospitalizations: 203.
Take PACLITAXEL Side Effects Survey or Share Your PACLITAXEL Story. Read More Here.

Showing 1-75 of 359 Next >

Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on Mar 15, 2007. Female patient, 70 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: anorexia, confusional state, constipation, dehydration, fatigue. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, DIGOXIN, COREG, TEMAZEPAM, SPIRONOLACTONE, RANITIDINE, LEVOTHYROXINE, PENTOXIFYLLINE. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Consumer or non-health professional from PORTUGAL on Feb 26, 2007. Female patient, 49 years of age, weighting 119.0 lb, was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: back pain, chest pain, erythema, hypertension, hypoaesthesia facial. PACLITAXEL dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported PACLITAXEL problem on Mar 19, 2007. Female patient, 45 years of age, was diagnosed with breast cancer metastatic and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, spinal compression fracture. PACLITAXEL dosage: unknown. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from UNITED STATES on Mar 21, 2007. Female patient, weighting 141.0 lb, was diagnosed with ovarian cancer and was treated with PACLITAXEL. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient died on 03/05/2007.

Health Professional from UNITED STATES reported PACLITAXEL problem on Mar 20, 2007. Female patient, 58 years of age, weighting 147.7 lb, was diagnosed with breast cancer metastatic and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: blood culture positive, coordination abnormal, escherichia infection, fusobacterium infection, myopathy toxic, peptostreptococcus infection. PACLITAXEL dosage: unknown. During the same period patient was treated with GEMZAR, BEVACIZUMAB, LIPITOR, LISINOPRIL, TOPROL, HYDROCHLOROTHIAZIDE, TRICOR. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Consumer or non-health professional from NORWAY on Feb 28, 2007. Female patient, 51 years of age, was diagnosed with ovarian cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: back pain, feeling hot, flushing, musculoskeletal stiffness. PACLITAXEL dosage: 310 MG QD IV. Patient recovered.

Health Professional from NORWAY reported PACLITAXEL problem on Feb 28, 2007. Female patient, 59 years of age, was diagnosed with uterine cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: feeling hot, flushing, heart rate increased, infusion related reaction, restlessness. PACLITAXEL dosage: 350 MG DAILY IV. Patient recovered.

PACLITAXEL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2007. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dehydration. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, PANAMAX, PROCHLORPERAZINE, MAXOLON, AMOXICILLIN, ONDANSETRON, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PACLITAXEL problem on Mar 06, 2007. Female patient, 60 years of age, was diagnosed with endometrial cancer, ovarian cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: arterial thrombosis, hepatic function abnormal, metastases to liver, thrombocytopenia, venous occlusion. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, HEPARIN, WARFARIN. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from UNITED KINGDOM on Mar 08, 2007. Female patient, 51 years of age, was diagnosed with ovarian cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, glomus tumour. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Pharmacist from UNITED STATES reported PACLITAXEL problem on Mar 27, 2007. Female patient, weighting 169.0 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: bone pain, rash. PACLITAXEL dosage: 148MG EVERY 7 DAYS IV DRIP. During the same period patient was treated with HERCEPTIN. Patient recovered.

PACLITAXEL problem was reported by a Physician from on Mar 16, 2007. Female patient, 59 years of age, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: blood culture positive. PACLITAXEL dosage: 324 MG, UNK. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported PACLITAXEL problem on Mar 16, 2007. Female patient, 50 years of age, was diagnosed with ovarian epithelial cancer recurrent and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, arrhythmia, blood potassium decreased, blood urea increased, cardiovascular disorder, cold sweat, cough, creatine urine increased, dysuria. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, DMXAA, LISINOPRIL W. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Consumer or non-health professional from SPAIN on Jan 22, 2007. Female patient, 71 years of age, was diagnosed with ovarian epithelial cancer recurrent and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: neutropenia, respiratory failure, respiratory tract infection. PACLITAXEL dosage: unknown. During the same period patient was treated with OMEPRAZOLE, FUROSEMIDE, PREDNISONE, SALBUTAMOL, IPRATROPIUM BROMIDE, BUDESONIDE, FENTANYL, LORAZEPAM. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported PACLITAXEL problem on Mar 28, 2007. Female patient was diagnosed with neoplasm malignant and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: alopecia, anaemia, anaphylactic reaction, anorexia, arthralgia, cardiac failure, cardiotoxicity, constipation, diarrhoea. PACLITAXEL dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CLEMASTINE FUMARATE, CIMETIDINE. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from UNITED STATES on Apr 03, 2007. Female patient, 63 years of age, weighting 174.2 lb, was diagnosed with non-small cell lung cancer, pain, gastrooesophageal reflux disease and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: anaemia, dehydration, thrombocytopenia. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, NORCO, COLACE, LUNESTA, PROTONIX, COUMADIN, MS CONTIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on Apr 03, 2007. Female patient, 70 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: anorexia, confusional state, constipation, dehydration, fatigue. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, DIGOXIN, COREG, TEMAZEPAM, SPIRONOLACTONE, RANITIDINE, LEVOTHYROXINE, PENTOXIFYLLINE. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from BELGIUM on Apr 05, 2007. Female patient, 62 years of age, weighting 127.9 lb, was diagnosed with endometrial cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: herpes simplex, neutropenia. PACLITAXEL dosage: unknown. During the same period patient was treated with CISPLATIN, ADRIAMYCIN PFS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PACLITAXEL problem on Apr 06, 2007. Female patient, 58 years of age, weighting 147.7 lb, was diagnosed with breast cancer metastatic and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: myopathy toxic. PACLITAXEL dosage: unknown. During the same period patient was treated with GEMZAR, BEVACIZUMAB, LIPITOR, LISINOPRIL, TOPROL, HYDROCHLOROTHIAZIDE, TRICOR. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from UNITED STATES on Apr 06, 2007. Female patient, 63 years of age, weighting 401.2 lb, was diagnosed with breast cancer metastatic and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: diverticulitis. PACLITAXEL dosage: unknown. During the same period patient was treated with BEVACIZUMAB, BACTRIM DS, HYDROCODONE TARTRATE, PRAVACHOL, ATENOLOL, CENTRUM SILVER, ENALAPRIL MALEATE, GLYBURIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from IRELAND reported PACLITAXEL problem on Mar 21, 2007. Female patient, 42 years of age, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood ph decreased, bone marrow failure, cardiac arrest, cellulitis, clostridial infection, diabetic coma, disease recurrence, disseminated intravascular coagulation. PACLITAXEL dosage: 175 MG/M2 PER_CYCLE. During the same period patient was treated with DEXAMETHASONE, ONDANSETRON, PEGFILGRASTIM, MOTILIUM, LANSOPRAZOLE. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from AUSTRIA on Mar 22, 2007. Female patient, 38 years of age, was diagnosed with breast cancer metastatic and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: amniotic fluid volume decreased, caesarean section, foetal disorder, foetal growth retardation, immature respiratory system, oligohydramnios, renal failure. PACLITAXEL dosage: 175 MG/M2. During the same period patient was treated with TRASTUZUMAB, CORTICOSTEROIDS. Patient recovered.

Health Professional from UNITED KINGDOM reported PACLITAXEL problem on Mar 21, 2007. Female patient, 65 years of age, weighting 110.2 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bronchospasm, tachypnoea. PACLITAXEL dosage: 80 MG/M2 PER_CYCLE; IV. Patient recovered.

PACLITAXEL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2007. Female patient, 61 years of age, was diagnosed with transitional cell carcinoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis, pulmonary toxicity. PACLITAXEL dosage: 110 MG/M2 PER_CYCLE IV. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE, DIPHENHYDRAMINE. Patient died.

Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on Mar 28, 2007. Female patient, 65 years of age, was diagnosed with transitional cell carcinoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, pulmonary toxicity, sepsis. PACLITAXEL dosage: 110 MG/M2 PER_CYCLE IV. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE, DIPHENHYDRAMINE. Patient died.

PACLITAXEL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2007. Female patient, 52 years of age, was diagnosed with transitional cell carcinoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, lung infiltration, pulmonary toxicity. PACLITAXEL dosage: 110 MG/M2 PER_CYCLE IV. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE, DIPHENHYDRAMINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on Mar 28, 2007. Female patient, 67 years of age, was diagnosed with transitional cell carcinoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, pulmonary toxicity. PACLITAXEL dosage: 110 MG/M2 PER_CYCLE IV. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE, DIPHENHYDRAMINE. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from UNITED STATES on Mar 28, 2007. Female patient, 59 years of age, was diagnosed with transitional cell carcinoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, lung infiltration, pulmonary toxicity. PACLITAXEL dosage: 110 MG/M2 PER_CYCLE IV. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE, DIPHENHYDRAMINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on Mar 28, 2007. Female patient, 60 years of age, was diagnosed with transitional cell carcinoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pulmonary oedema, pulmonary toxicity. PACLITAXEL dosage: 110 MG/M2 PER_CYCLE IV. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE, DIPHENHYDRAMINE. Patient recovered.

PACLITAXEL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2007. Male patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dehydration. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, PANAMAX, PROCHLORPERAZINE, MAXOLON, BACTRIM, MYLANTA, COLOXYL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on Feb 05, 2007. Female patient, 31 years of age, weighting 156.5 lb, was diagnosed with ovarian cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: rash. PACLITAXEL dosage: unknown. During the same period patient was treated with PARAPLATIN, PREMARIN, TYLENOL, DECADRON, ZOFRAN, ATIVAN, BACTROBAN. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from BELGIUM on Apr 24, 2007. Female patient, 62 years of age, weighting 127.9 lb, was diagnosed with endometrial cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: herpes simplex, neutropenia. PACLITAXEL dosage: unknown. During the same period patient was treated with CISPLATIN, ADRIAMYCIN PFS. Patient was hospitalized. Patient recovered.

Health Professional from KOREA, REPUBLIC OF reported PACLITAXEL problem on Apr 26, 2007. Female patient, 50 years of age, was diagnosed with ovarian epithelial cancer, acute myeloid leukaemia and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, anaemia, asthenia, renal failure acute, thrombocytopenia. PACLITAXEL dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE, TOPOTECAN, IDARUBICIN, HEMATOPOETIC PROGENITOR CELLS, BEHENOYL ARABINOFURANOSYLCYTOSINE. Patient was hospitalized. Patient died.

PACLITAXEL problem was reported by a Health Professional from GERMANY on Apr 27, 2007. Female patient, 46 years of age, weighting 282.2 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: nervous system disorder. PACLITAXEL dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, EPIRUBICIN, LEVOTHYROXINE, VOLTAREN. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported PACLITAXEL problem on Apr 19, 2007. Female patient, 70 years of age, was diagnosed with lung neoplasm malignant and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: bronchospasm, hypotension, rash, tachycardia. PACLITAXEL dosage: 298 MG IV. During the same period patient was treated with BENDROFLUMETHIAZIDE, ENALAPRIL, FELODIPINE, MOVICOL. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 19, 2007. Female patient, 70 years of age, was diagnosed with lung neoplasm malignant and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: bronchospasm, hypotension, rash, tachycardia. PACLITAXEL dosage: 298 MG, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PACLITAXEL problem on May 07, 2007. Male patient was diagnosed with lung neoplasm malignant and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood potassium decreased, brain natriuretic peptide increased, dyspnoea, fibrin d dimer increased, heart rate increased, hyperglycaemia, hypotension, hypoxia. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient died on 04/21/2007.

PACLITAXEL problem was reported by a Health Professional from UNITED KINGDOM on May 08, 2007. Female patient, 42 years of age, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, cardiac arrest, cellulitis, clostridial infection, diabetic ketoacidotic hyperglycaemic coma, disseminated intravascular coagulation, female genital tract fistula, myocardial infarction, neuropathy. PACLITAXEL dosage: unknown. During the same period patient was treated with PEGFILGRASTIM, DEXAMETHASONE, ONDANSETRON, MOTILIUM, LANSOPRAZOLE, DOMPERIDONE, ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on May 07, 2007. Female patient, 52 years of age, weighting 160.0 lb, was diagnosed with coronary artery disease and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, heart rate decreased, hypotension, loss of consciousness, malaise, nausea, vomiting. PACLITAXEL dosage: unknown. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from IRELAND on May 08, 2007. Female patient, 42 years of age, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, cardiac arrest, cellulitis, clostridial infection, diabetic ketoacidotic hyperglycaemic coma, disseminated intravascular coagulation, female genital tract fistula, malignant neoplasm progression, myocardial infarction. PACLITAXEL dosage: unknown. During the same period patient was treated with DEXAMETHASONE, DOMPERIDONE, LANSOPRAZOLE, ONDANSETRON, PEGFILGRASTIM, MOTILIUM, ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died.

Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on May 14, 2007. Female patient, 76 years of age, weighting 202.8 lb, was diagnosed with non-small cell lung cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: anorexia, arthralgia, bradycardia, cardio-respiratory arrest, coma, constipation, dysarthria, dyspnoea at rest, facial palsy. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, FOSAMAX, ATENOLOL, HYDROCHLOROTHIAZIDE, ANZEMET, COMPAZINE, ALLOPURINOL. Patient was hospitalized. Patient died on 12/29/2005.

PACLITAXEL problem was reported by a Consumer or non-health professional from LUXEMBOURG on Apr 25, 2007. Female patient was diagnosed with breast neoplasm and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: cyanosis, hypertension, malaise, oxygen saturation decreased, petit mal epilepsy, tachycardia. PACLITAXEL dosage: 241 MG INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with GEMCITABINE. Patient recovered.

Consumer or non-health professional from LUXEMBOURG reported PACLITAXEL problem on May 02, 2007. Female patient, 50 years of age, was diagnosed with bone disorder, breast neoplasm, liver disorder and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: cyanosis, hypertension, loss of consciousness, malaise, oxygen saturation decreased, tachycardia. PACLITAXEL dosage: (241 MG, J1=J14), INTRAVENOUS. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE, DEXCHLORPHENIRAMINE, RANITIDINE, ONDANSETRON. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from JAPAN on May 17, 2007. Male patient, 69 years of age, weighting 99.21 lb, was diagnosed with oesophageal carcinoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: anorexia, haemoglobin decreased, leukopenia, neutropenia, thrombocytopenia. PACLITAXEL dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported PACLITAXEL problem on May 09, 2007. Female patient, 42 years of age, was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bone marrow failure, cardiac arrest, cellulitis, cerebral infarction, clostridial infection, dermatitis bullous, diabetic coma, diabetic ketoacidosis. PACLITAXEL dosage: 175 MG/M2 PER_CYCLE. During the same period patient was treated with DEXAMETHASONE, ONDANSETRON, PEGFILGRASTIM, MOTILIUM. Patient recovered.

PACLITAXEL problem was reported by a Pharmacist from UNITED STATES on May 21, 2007. Male patient, 55 years of age, weighting 145.0 lb, was diagnosed with non-small cell lung cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, chest pain, haemoptysis, iron deficiency anaemia, renal failure acute. PACLITAXEL dosage: 150MG QWK IV. During the same period patient was treated with CARBOPLATIN, DIPHENHYDRAMINE, FAMOTIDINE, DEXAMETHASONE, ONDANSETRON, APREPITANT, PERCOCET, PREVACID. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from IRELAND reported PACLITAXEL problem on May 28, 2007. Female patient, 42 years of age, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, cardiac arrest, cellulitis, clostridial infection, diabetic ketoacidotic hyperglycaemic coma, disseminated intravascular coagulation, female genital tract fistula, malignant neoplasm progression, myocardial infarction. PACLITAXEL dosage: unknown. During the same period patient was treated with DEXAMETHASONE, DOMPERIDONE, LANSOPRAZOLE, ONDANSETRON, PEGFILGRASTIM, MOTILIUM, ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died.

PACLITAXEL problem was reported by a Consumer or non-health professional from PORTUGAL on May 16, 2007. Female patient, 58 years of age, weighting 165.3 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: erythema, feeling hot, hypertension, infusion related reaction. PACLITAXEL dosage: 235 MG TOTAL IV. During the same period patient was treated with VINORELBINE. Patient recovered.

Health Professional from PORTUGAL reported PACLITAXEL problem on May 16, 2007. Female patient, 57 years of age, weighting 101.4 lb, was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, erythema, feeling hot, hypertension, pain in extremity, pruritus, tachycardia. PACLITAXEL dosage: unknown. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from UNITED STATES on May 31, 2007. Female patient, 69 years of age, weighting 231.5 lb, was diagnosed with non-small cell lung cancer, pain and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, nausea, vomiting. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, CARBAMAZEPINE, ZOFRAN, COMPAZINE, TYLENOL, AMOXICILLIN. Patient was hospitalized. Patient recovered.

Health Professional from JAPAN reported PACLITAXEL problem on June 04, 2007. Male patient, 69 years of age, weighting 99.21 lb, was diagnosed with oesophageal carcinoma, hypothyroidism, gastritis and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: anorexia, haemoglobin decreased, leukopenia, neutropenia, thrombocytopenia. PACLITAXEL dosage: unknown. During the same period patient was treated with DIPHENHYDRAMINE, RANITIDINE, DEXAMETHASONE, THYRADIN S, GASLON N. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from UNITED STATES on June 07, 2007. Male patient, 72 years of age, weighting 146.4 lb, was diagnosed with non-small cell lung cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dehydration, nausea, renal failure acute, syncope, vomiting. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PACLITAXEL problem on June 08, 2007. Female patient, 56 years of age, weighting 158.7 lb, was diagnosed with neoplasm malignant and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, leukopenia, neutropenia, thrombocytopenia. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, SUNITINIB MALATE, GLUCOPHAGE, ACTOS, LANTUS, VITAMIN CAP, HUMALOG. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Physician from UNITED STATES on May 29, 2007. Female patient, 67 years of age, was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, leukocytosis. PACLITAXEL dosage: unknown. During the same period patient was treated with PEGFILGRASTIM, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PACLITAXEL problem on June 12, 2007. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with oesophageal carcinoma, interstitial lung disease, hypertension, gastritis prophylaxis, constipation, insomnia, pyrexia and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: respiratory failure, tuberculosis. PACLITAXEL dosage: unknown. During the same period patient was treated with PREDONINE, AMLODIN, GASTER D, PURSENNID, AMOBAN, VOLTAREN. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Pharmacist from UNITED STATES on June 13, 2007. Male patient, weighting 173.0 lb, was diagnosed with neoplasm malignant and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, infusion related reaction, loss of consciousness, respiratory arrest. PACLITAXEL dosage: 153MG Q28 DAYS IV. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported PACLITAXEL problem on June 13, 2007. Female patient, 51 years of age, was diagnosed with neoplasm malignant and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea, flushing, infusion related reaction. PACLITAXEL dosage: 126 MG QWEEK IV. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from JAPAN on June 13, 2007. Male patient, 69 years of age, weighting 99.21 lb, was diagnosed with oesophageal carcinoma, hypothyroidism, gastritis and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: anorexia, haemoglobin decreased, leukopenia, neutropenia, thrombocytopenia. PACLITAXEL dosage: unknown. During the same period patient was treated with DIPHENHYDRAMINE, RANITIDINE, DEXAMETHASONE, THYRADIN S, GASLON N. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PACLITAXEL problem on June 15, 2007. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with oesophageal carcinoma, interstitial lung disease, hypertension, gastritis prophylaxis, constipation, insomnia, pyrexia and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: respiratory failure, tuberculosis. PACLITAXEL dosage: unknown. During the same period patient was treated with PREDONINE, AMLODIN, GASTER D, PURSENNID, AMOBAN, VOLTAREN. Patient was hospitalized. Patient died on 06/15/2007.

PACLITAXEL problem was reported by a Health Professional from UNITED STATES on June 15, 2007. Female patient, 56 years of age, weighting 158.7 lb, was diagnosed with pancreatic carcinoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, leukopenia, neutropenia, thrombocytopenia. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, SUTENT, GLUCOPHAGE, ACTOS, LANTUS, VITAMIN CAP, HUMALOG. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported PACLITAXEL problem on June 18, 2007. Male patient, 57 years of age, weighting 172.0 lb, was diagnosed with nausea, hypertension, gastrooesophageal reflux disease, pain and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, dehydration, fatigue. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE, COMPAZINE, HYDROCHLOROTHIAZIDE, LOTREL, PROTONIX, MS CONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Consumer or non-health professional from SPAIN on May 29, 2007. Female patient, 77 years of age, was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hypocalcaemia, hypokalaemia, hypomagnesaemia, hyponatraemia, vomiting. PACLITAXEL dosage: ?? (100 MG, CYCLICAL) INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with CARBOPLATIN, ONDANSETRON, DEXAMETHASONE. Patient died.

Health Professional from UNITED STATES reported PACLITAXEL problem on June 18, 2007. Male patient, 66 years of age, was diagnosed with angiosarcoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: corneal staining, dacryostenosis acquired, ectropion, intraocular pressure increased, lacrimation increased, punctate keratitis. PACLITAXEL dosage: unknown. Patient recovered.

PACLITAXEL problem was reported by a Consumer or non-health professional from FINLAND on May 31, 2007. Female patient, 60 years of age, was diagnosed with uterine cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. PACLITAXEL dosage: 322 MG IV. During the same period patient was treated with CRAMPITON, METOPRAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on June 25, 2007. Male patient, 75 years of age, weighting 112.4 lb, was diagnosed with non-small cell lung cancer, diabetes mellitus and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, diarrhoea, dyspnoea, sepsis. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, INSULIN, GRANISETRON, DEXAMETHASONE, EFCORLIN, PROMETHAZINE, RANITIDINE, CHLORIDE. Patient was hospitalized. Patient died on 08/23/2006.

PACLITAXEL problem was reported by a Consumer or non-health professional from JAPAN on June 21, 2007. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with oesophageal carcinoma, interstitial lung disease, hypertension, gastritis prophylaxis, constipation, insomnia, pyrexia and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: respiratory failure, tuberculosis. PACLITAXEL dosage: unknown. During the same period patient was treated with PREDONINE, AMLODIN, GASTER D, PURSENNID, AMOBAN, VOLTAREN. Patient was hospitalized. Patient died on 06/15/2007.

Health Professional from UNITED STATES reported PACLITAXEL problem on June 25, 2007. Female patient, 65 years of age, weighting 134.5 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hypoxia, oedema peripheral, pleural effusion. PACLITAXEL dosage: unknown. During the same period patient was treated with SUTENT, VITAMIN CAP, SELENIUM SULFIDE, VITAMIN A, CAPSAICIN, GINKOBIL. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Consumer or non-health professional from NORWAY on June 12, 2007. Female patient, 61 years of age, was diagnosed with breast cancer metastatic and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hypoxia. PACLITAXEL dosage: unknown. During the same period patient was treated with OXYNORM, ACETAMINOPHEN, LEVAXIN, TRUXAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FINLAND reported PACLITAXEL problem on June 14, 2007. Female patient, 61 years of age, was diagnosed with uterine cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: obstruction, pharyngeal oedema. PACLITAXEL dosage: 294 MG FREQ IV. During the same period patient was treated with PULMICORT MFR, BRICANYL, RETAFYLLIN, SEREVENT MFR, PANADOL, OXANEST, KLEXANE. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from SPAIN on June 22, 2006. Female patient, 71 years of age, was diagnosed with ovarian epithelial cancer recurrent and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, respiratory failure, respiratory tract infection. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, OMEPRAZOLE, FUROSEMIDE, PREDNISONE, SALBUTAMOL, IPRATROPIUM BROMIDE, BUDESONIDE, FENTANYL TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on June 19, 2006. Male patient, 77 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, hyperglycaemia. PACLITAXEL dosage: unknown. During the same period patient was treated with CARBOPLATIN, IBUPROFEN, TRAMADOL, MORPHINE, DARBEPOETIN ALFA, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Pharmacist from UNITED STATES on July 05, 2006. Female patient, 45 years of age, weighting 166.0 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pleurisy, pulmonary toxicity. PACLITAXEL dosage: 312 MG FORTNIGHTLY IV. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported PACLITAXEL problem on June 27, 2006. Female patient, 55 years of age, weighting 246.0 lb, was diagnosed with breast cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis, pulmonary toxicity. PACLITAXEL dosage: 315 MG ONCE IV. Patient was hospitalized. Patient recovered.

PACLITAXEL problem was reported by a Health Professional from BELGIUM on June 09, 2006. Female patient, 65 years of age, was diagnosed with endometrial cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dehydration, pyrexia. PACLITAXEL dosage: unknown. During the same period patient was treated with DOXORUBICIN, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from HUNGARY reported PACLITAXEL problem on June 30, 2006. Female patient, 56 years of age, weighting 172.0 lb, was diagnosed with ovarian cancer and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: arthralgia, back pain, chest pain, flushing, neuralgia. PACLITAXEL dosage: 175 MG/M2. During the same period patient was treated with CALCIMUSC, DOLARGAN. Patient recovered.

Showing 1-75 of 359 Next >